Drug intelligence / Profile preview

lapyrium

Development stage: Unknown
Modality: Small Molecules
Administration: Topical, Vaginal

Overview

Lapyrium is a quaternary ammonium compound (QAC) with antimicrobial properties. Its primary mechanism of action involves associating with the negatively charged cell membrane of bacterial cells, followed by insertion of its side chain and disruption of the cell membrane. This leads to leakage of cellular contents and eventual cell lysis. QACs like lapyrium are typically more effective against Gram-positive bacteria due to their single cell membrane structure[8]. Lapyrium is used as an antimicrobial agent.

Beyond the preview

Go deeper on lapyrium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on lapyrium.

Explore the full profile